NFKB1 and prostate cancer: GDF15 has been shown to block NFκB activity in many cell types, including prostate cancer cells, osteoclasts and colon cancer cells8, 32, and it is possible that it performs its role in LPS-mediated AKI and myocardial dysfunction by blocking the NFκB-dependent production of cytokines.